Psocare: Italy Shows the Way in Postmarketing Studies

will perform coordinated postmarketing surveillance studies to monitor the effectiveness and safety of systemic agents, including biologics, in the treatment of psoriasis. Accordingly, international data can be pooled to reach sufficient power and new drugs can be easily monitored in the future. Established registries try to link to Psonet and new ones are under construction to use the Psocare framework to collect a standardized 'core set' of variables. The countries that participate include Italy, France, Israel, Portugal, Spain, Sweden, the Netherlands and the UK. Moreover, the establishment of a multidisciplinary and international group of investigators sharing resources and activities may increase the quality of (pharmaco)epidemiological studies and stimulate the development of independent pragmatic randomized controlled trials (RCT) that are needed by patients and physicians